Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Micardis Hct Patent Expiration

Micardis Hct is a drug owned by Boehringer Ingelheim. It is protected by 2 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Jan 10, 2020. Details of Micardis Hct's patents and their expiration are given in the table below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6358986 Polymorphs of telmisartan
Jan, 2020

(4 years ago)

Expired
US5591762 Benzimidazoles useful as angiotensin-11 antagonists
Jan, 2014

(10 years ago)

Expired

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

US patents provide insights into the exclusivity only within the United States, but Micardis Hct is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Micardis Hct's family patents as well as insights into ongoing legal events on those patents.

Micardis Hct's Family Patents


Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List


Generic Launch

Generic Release Date:

Micardis Hct's generic launch date based on the expiry of its last outstanding patent is estimated to be Jan 10, 2020 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)

Micardis Hct Generic API suppliers:

Hydrochlorothiazide; Telmisartan is the generic name for the brand Micardis Hct. 9 different companies have already filed for the generic of Micardis Hct, with Alembic having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Micardis Hct's generic

How can I launch a generic of Micardis Hct before its drug patent expiration? :

You can seek FDA approval to launch a generic drug before the expiration of Micardis Hct's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the Micardis Hct's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Given below are the details of the already filed Para IV certificates on Micardis Hct -

Strength Submission Date ANDA(s) Filed First applicant approval Last patent expiry 180 day status
80 mg/12.5 mg and 40 mg/12.5 mg 31 Dec, 2008 1 10 Jan, 2020 Extinguished

Alternative Brands for Micardis Hct

Micardis Hct which is used for lowering high blood pressure., has several other brand drugs in the same treatment category . Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.

Drug Owner Drug Name Treatment Area
Abbott
Hytrin Used for treating hypertension and symptomatic benign prostatic hyperplasia.
Abbvie
Teveten Used for managing high blood pressure.
Teveten Hct Used for managing high blood pressure.
Adhera
Prestalia Used for treating high blood pressure.
Allergan
Bystolic Used for treating high blood pressure.
Ani Pharms
Atacand Hct Used for treating high blood pressure.
Azurity
Edarbi Used for lowering blood pressure.
Epaned Used for managing heart failure and hypertension.
Edarbyclor Used for managing high blood pressure.
Boehringer Ingelheim
Twynsta Used for managing high blood pressure.
Micardis Used for the treatment of cardiovascular conditions such as myocardial infarction, hypertension, and stroke.
Cosette
Azor Used for managing high blood pressure.
Benicar Used for lowering high blood pressure.
Tribenzor Used for lowering high blood pressure.
Benicar Hct Used for managing high blood pressure.
Noden Pharma
Tekturna Used for treating high blood pressure.
Tekturna Hct Used for lowering high blood pressure.
Novartis
Diovan Used for managing hypertension and reducing cardiovascular mortality in stable patients with left ventricular failure or dysfunction post-myocardial infarction.
Exforge Used for treating high blood pressure.
Tekamlo Used for treating high blood pressure.
Valturna Used for managing high blood pressure.
Amturnide Used for lowering high blood pressure (hypertension).
Diovan Hct Used for treating high blood pressure.
Exforge Hct Used for treating high blood pressure.
Upjohn
Inspra Used for treating hypertension, heart failure, and conditions related to hyperaldosteronism, often in combination with an ACE inhibitor.
Waylis Therap
Coreg Cr Used for managing congestive heart failure and hypertension to reduce mortality.





About Micardis Hct

Micardis Hct is a drug owned by Boehringer Ingelheim. It is used for lowering high blood pressure. Micardis Hct uses Hydrochlorothiazide; Telmisartan as an active ingredient. Micardis Hct was launched by Boehringer Ingelheim in 2000.

Approval Date:

Micardis Hct was approved by FDA for market use on 17 November, 2000.

Active Ingredient:

Micardis Hct uses Hydrochlorothiazide; Telmisartan as the active ingredient. Check out other Drugs and Companies using Hydrochlorothiazide; Telmisartan ingredient

Treatment:

Micardis Hct is used for lowering high blood pressure.

Dosage:

Micardis Hct is available in tablet form for oral use. Given below is detailed information on Dosage -

Strength Dosage Form Availability Application Pathway
12.5MG;80MG TABLET Prescription ORAL
12.5MG;40MG TABLET Prescription ORAL
25MG;80MG TABLET Prescription ORAL